Cascadia Capital Advises Summit Imaging on its Acquisition by RS&A, a portfolio company of Sheridan Capital Partners

Summit Imaging, Inc. Logo has been acquired by RS&A, LLC, a portfolio company of Sheridan Capital Partners Logo

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Summit Imaging, Inc. (“Summit”), a technology enabled service organization that focuses on repairs and services for ultrasound and mammography imaging equipment, in its acquisition by RS&A, LLC (“RSA”), a portfolio company of Sheridan Capital Partners, a healthcare focused private equity firm.

Founded in 2006, Summit is a tech-enabled provider of medical imaging equipment repair, refurbishment, and exchange services to healthcare facilities, independent service organizations, and OEMs across North America, primarily focused on ultrasound and mammography. Summit’s deep industry expertise, technical capabilities, and proprietary software solutions perfectly complement RSA’s existing service offering and will augment their collective ability to deliver critical support to their healthcare customers.

RSA is a North Carolina-based medical device independent service provider for radiotherapy equipment, most notably external beam linear accelerators (“LINACs”). Since 1995, RSA has supported the oncology community through equipment life cycle management, maintenance, parts, and removals/installations.

“The entire Summit team and I are elated about our partnership with [CEO] DJ Conrad and the RSA team,” said Larry Nguyen, the Founder of Summit, and newly appointed CIO of RSA. “Our teams are fundamentally aligned in our cultural values, our commitment to our clients, and our desire to deliver the highest-quality services in direct support of healthcare providers, and the service community to improve patient care.”

“As the medical equipment service and repair space evolves, Summit Imaging will continue to drive growth through their broad electronic expertise, proprietary software, and tech enabled, differentiated offerings. Larry and the team have found a compelling strategic partner and we look forward to their collective future success,” said Adam Stormoen, Managing Director and Head of Medical Devices at Cascadia Capital. “We are pleased to have delivered another successful outcome in the medical equipment service and repair sector and look forward to continuing to support clients in the space.”

The acquisition represents another successful transaction for Cascadia’s healthcare team, and another great outcome for a client in the medical equipment service, maintenance and repair sector following the recent sale of 626 Holdings to Peak Rock Capital.

For more information about this transaction, please contact:

Adam Stormoen
Managing Director
astormoen@cascadiacapital.com
(612) 260-8060

Other senior members of the Cascadia Healthcare team include:

Kevin Cable
Managing Director
kcable@cascadiacapital.com
(206) 696-7922

Vitaliy Marchenko
Senior Vice President
vmarchenko@cascadiacapital.com
(253) 314-3143

Novan Le
Vice President
nle@cascadiacapital.com
(206) 436-2510

Back to News
Loading